Advertisement
Australia markets closed
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • AUD/USD

    0.6421
    -0.0004 (-0.07%)
     
  • OIL

    83.30
    +0.57 (+0.69%)
     
  • GOLD

    2,409.30
    +11.30 (+0.47%)
     
  • Bitcoin AUD

    100,276.27
    +1,676.22 (+1.70%)
     
  • CMC Crypto 200

    1,382.83
    +70.21 (+5.35%)
     
  • AUD/EUR

    0.6025
    -0.0006 (-0.10%)
     
  • AUD/NZD

    1.0904
    +0.0029 (+0.27%)
     
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NASDAQ

    17,034.80
    -359.51 (-2.07%)
     
  • FTSE

    7,895.85
    +18.80 (+0.24%)
     
  • Dow Jones

    37,944.60
    +169.22 (+0.45%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

MindMed Interim CEO on the growing competition in psychedelics industry

Robert Barrow, MindMed Interim CEO, joins Yahoo Finance to discuss then transition in MindMed’s CEO, future outlook for the company and the psychedelics industry.